Steelhead Partners »

Bridgebio Pharma shares owned by Steelhead Partners

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Steelhead Partners from 13F filings

Historical chart of Steelhead Partners investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Steelhead Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Steelhead Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $127B 70M 1809.04

More positions owned by Steelhead Partners

Bbio 2 1/2 03/15/27 Note 2.500% 3/1 (Principal)
On 0 05/01/27 Note 5/0 (Principal)
Uber 0 7/8 12/01/28 Note 0.875%12/0 (Principal)
Aeis 2 1/2 09/15/28 Note 2.500% 9/1 (Principal)
Akam 1 1/8 02/15/29 Note 1.125% 2/1 (Principal)
Lcii 3 03/01/30 Note 3.000% 3/0 (Principal)
Alrm 2 1/4 06/01/29 Note 2.250% 6/0 (Principal)
Net 0 08/15/26 Note 8/1 (Principal)
Alny 1 09/15/27 Note 1.000% 9/1 (Principal)
DXCM 0 3/8 05/15/28 Note 0.375% 5/1 (Principal)
NTNX 0 1/4 10/01/27 Note 0.250%10/0 (Principal)
WK 1 1/4 08/15/28 Note 1.250% 8/1 (Principal)
Akam 0 3/8 09/01/27 Note 0.375% 9/0 (Principal)
Irtc 1 1/2 09/01/29 Note 1.500% 9/0 (Principal)
Itri 1 3/8 07/15/30 Note 1.375% 7/1 (Principal)

View all positions for Steelhead Partners

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Linden Advisors
Steelhead Partners
Capstone Investment Advisors
Lazard Asset Management
Millennium Management
FMR
Graham Capital Management
683 Capital Management
Aristeia Capital
Tenor Capital Management
M&G
State Street Corporation
DeepCurrents Investment Group
BlackRock

View all funds holding Bridgebio Pharma